These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 31570099)

  • 1. 90-gene signature assay for tissue origin diagnosis of brain metastases.
    Zheng Y; Ding Y; Wang Q; Sun Y; Teng X; Gao Q; Zhong W; Lou X; Xiao C; Chen C; Xu Q; Xu N
    J Transl Med; 2019 Oct; 17(1):331. PubMed ID: 31570099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene expression profiles help identify the tissue of origin for metastatic brain cancers.
    Wu AH; Drees JC; Wang H; VandenBerg SR; Lal A; Henner WD; Pillai R
    Diagn Pathol; 2010 Apr; 5():26. PubMed ID: 20420692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accurate classification of metastatic brain tumors using a novel microRNA-based test.
    Mueller WC; Spector Y; Edmonston TB; St Cyr B; Jaeger D; Lass U; Aharonov R; Rosenwald S; Chajut A
    Oncologist; 2011; 16(2):165-74. PubMed ID: 21273512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying primary site of lung-limited Cancer of unknown primary based on relative gene expression orderings.
    Li M; Li H; Hong G; Tang Z; Liu G; Lin X; Lin M; Qi L; Guo Z
    BMC Cancer; 2019 Jan; 19(1):67. PubMed ID: 30642283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A specific gene expression signature for visceral organ metastasis in breast cancer.
    Savci-Heijink CD; Halfwerk H; Koster J; Horlings HM; van de Vijver MJ
    BMC Cancer; 2019 Apr; 19(1):333. PubMed ID: 30961553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting early brain metastases based on clinicopathological factors and gene expression analysis in advanced HER2-positive breast cancer patients.
    Duchnowska R; Jassem J; Goswami CP; Dundar M; Gökmen-Polar Y; Li L; Woditschka S; Biernat W; Sosińska-Mielcarek K; Czartoryska-Arłukowicz B; Radecka B; Tomasevic Z; Stępniak P; Wojdan K; Sledge GW; Steeg PS; Badve S
    J Neurooncol; 2015 Mar; 122(1):205-16. PubMed ID: 25559688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of a new tumor-based gene signature predicting prognosis of HBV/HCV-included resected hepatocellular carcinoma patients.
    Zhu GQ; Yang Y; Chen EB; Wang B; Xiao K; Shi SM; Zhou ZJ; Zhou SL; Wang Z; Shi YH; Fan J; Zhou J; Liu TS; Dai Z
    J Transl Med; 2019 Jun; 17(1):203. PubMed ID: 31215439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical testing of BRAF V600E status in 1,120 tumor tissue samples of patients with brain metastases.
    Capper D; Berghoff AS; Magerle M; Ilhan A; Wöhrer A; Hackl M; Pichler J; Pusch S; Meyer J; Habel A; Petzelbauer P; Birner P; von Deimling A; Preusser M
    Acta Neuropathol; 2012 Feb; 123(2):223-33. PubMed ID: 22012135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression profiling of angiogenesis-related genes in brain metastases of lung cancer and melanoma.
    Ilhan-Mutlu A; Siehs C; Berghoff AS; Ricken G; Widhalm G; Wagner L; Preusser M
    Tumour Biol; 2016 Jan; 37(1):1173-82. PubMed ID: 26277786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genes associated with increased brain metastasis risk in non-small cell lung cancer: Comprehensive genomic profiling of 61 resected brain metastases versus primary non-small cell lung cancer (Guangdong Association Study of Thoracic Oncology 1036).
    Wang H; Ou Q; Li D; Qin T; Bao H; Hou X; Wang K; Wang F; Deng Q; Liang J; Zheng W; Wu X; Wang X; Shao YW; Mou Y; Chen L
    Cancer; 2019 Oct; 125(20):3535-3544. PubMed ID: 31287555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the molecular profile of brain metastases from colorectal cancer and corresponding primary tumors.
    Aprile G; Casagrande M; De Maglio G; Fontanella C; Rihawi K; Bonotto M; Pisa FE; Tuniz F; Pizzolitto S; Fasola G
    Future Oncol; 2017 Jan; 13(2):135-144. PubMed ID: 27578453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene Expression Profiling for Diagnosis of Triple-Negative Breast Cancer: A Multicenter, Retrospective Cohort Study.
    Wang Q; Xu M; Sun Y; Chen J; Chen C; Qian C; Chen Y; Cao L; Xu Q; Du X; Yang W
    Front Oncol; 2019; 9():354. PubMed ID: 31134153
    [No Abstract]   [Full Text] [Related]  

  • 13. Transcriptome Analyses Identify a Metabolic Gene Signature Indicative of Dedifferentiation of Papillary Thyroid Cancer.
    Ma B; Jiang H; Wen D; Hu J; Han L; Liu W; Xu W; Shi X; Wei W; Liao T; Wang Y; Lu Z; Wang Y; Ji Q
    J Clin Endocrinol Metab; 2019 Sep; 104(9):3713-3725. PubMed ID: 30942873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and Clinical Validation of a 90-Gene Expression Assay for Identifying Tumor Tissue Origin.
    Ye Q; Wang Q; Qi P; Chen J; Sun Y; Jin S; Ren W; Chen C; Liu M; Xu M; Ji G; Yang J; Nie L; Xu Q; Huang D; Du X; Zhou X
    J Mol Diagn; 2020 Sep; 22(9):1139-1150. PubMed ID: 32610162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A miRNA-Based Signature Detected in Primary Melanoma Tissue Predicts Development of Brain Metastasis.
    Hanniford D; Zhong J; Koetz L; Gaziel-Sovran A; Lackaye DJ; Shang S; Pavlick A; Shapiro R; Berman R; Darvishian F; Shao Y; Osman I; Hernando E
    Clin Cancer Res; 2015 Nov; 21(21):4903-12. PubMed ID: 26089374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pan-cancer transcriptome analysis reveals a gene expression signature for the identification of tumor tissue origin.
    Xu Q; Chen J; Ni S; Tan C; Xu M; Dong L; Yuan L; Wang Q; Du X
    Mod Pathol; 2016 Jun; 29(6):546-56. PubMed ID: 26990976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value and their clinical implication of 89-gene signature in glioma.
    Shahid M; Cho KM; Nguyen MN; Choi TG; Jo YH; Aryal SN; Yoo JY; Yun HR; Lee JW; Eun YG; Lee JS; Kang I; Ha J; Yoon HJ; Kim SY; Kim SS
    Oncotarget; 2016 Aug; 7(32):51237-51250. PubMed ID: 27323413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of molecular scores and gene expression signatures in primary breast cancer, local recurrences and brain metastases.
    Bustamante Eduardo M; Popovici V; Imboden S; Aebi S; Ballabio N; Altermatt HJ; Günthert A; Jaggi R
    BMC Cancer; 2019 Jun; 19(1):549. PubMed ID: 31174485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for brain metastases in patients with metastatic colorectal cancer.
    Christensen TD; Palshof JA; Larsen FO; Høgdall E; Poulsen TS; Pfeiffer P; Jensen BV; Yilmaz MK; Christensen IJ; Nielsen D
    Acta Oncol; 2017 May; 56(5):639-645. PubMed ID: 28447565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrated genomic and transcriptomic analysis of human brain metastases identifies alterations of potential clinical significance.
    Saunus JM; Quinn MC; Patch AM; Pearson JV; Bailey PJ; Nones K; McCart Reed AE; Miller D; Wilson PJ; Al-Ejeh F; Mariasegaram M; Lau Q; Withers T; Jeffree RL; Reid LE; Da Silva L; Matsika A; Niland CM; Cummings MC; Bruxner TJ; Christ AN; Harliwong I; Idrisoglu S; Manning S; Nourse C; Nourbakhsh E; Wani S; Anderson MJ; Fink JL; Holmes O; Kazakoff S; Leonard C; Newell F; Taylor D; Waddell N; Wood S; Xu Q; Kassahn KS; Narayanan V; Taib NA; Teo SH; Chow YP; kConFab ; Jat PS; Brandner S; Flanagan AM; Khanna KK; Chenevix-Trench G; Grimmond SM; Simpson PT; Waddell N; Lakhani SR
    J Pathol; 2015 Nov; 237(3):363-78. PubMed ID: 26172396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.